Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H15N3O3 |
Molecular Weight | 249.2658 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCOC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
InChI
InChIKey=RAOCRURYZCVHMG-UHFFFAOYSA-N
InChI=1S/C12H15N3O3/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
DescriptionSources: https://www.drugbank.ca/drugs/DB04910
Sources: https://www.drugbank.ca/drugs/DB04910
Oxibendazole is an anthelmintics drug which is used to protect against roundworms, strongyles, threadworms, pinworms and lungworm infestations in horses and other domestic pets. Oxibendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P50719 Gene ID: NA Gene Symbol: NA Target Organism: Haemonchus contortus (Barber pole worm) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3755220 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Anthelcide EQ Approved UseAnthelcide EQ Paste is indicated for removal and control of: large strongyles (Strongylus edentatus, S. equinus, S. vulgaris); small strongyles (species of the genera Cylicostephanus, Cylicocyclus, Cyathostomum, Triodontophorus, Cylicodontophorus, and Gyalocephalus); large roundworms (Parascaris equorum); pinworms (Oxyuris equi) including various larval stages; and threadworms (Strongyloides westeri). |
PubMed
Title | Date | PubMed |
---|---|---|
In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles. | 1994 Feb |
|
Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. | 1995 Jun |
|
Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice. | 1995 Oct |
|
In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives. | 1997 Dec |
|
Ultrastructural changes in Ascaris suum after oxibendazole treatment. | 1998 Feb |
|
Continuance of studies on Population S benzimidazole-resistant small strongyles in a Shetland pony herd in Kentucky: effect of pyrantel pamoate (1992-1999). | 2001 Jan 20 |
|
One season of pasture exposure fails to induce a protective resistance to cyathostomes but increases numbers of hypobiotic third-stage larvae. | 2002 Aug |
|
An introductory survey of helminth control practices in south africa and anthelmintic resistance on Thoroughbred stud farms in the Western Cape Province. | 2002 Dec |
|
Plasma disposition, faecal excretion and in vitro metabolism of oxibendazole following oral administration in horses. | 2002 Feb |
|
Evaluation of tests for anthelmintic resistance in cyathostomes. | 2002 Jul 2 |
|
Development and validation of a liquid chromatographic-electrospray tandem mass spectrometric multiresidue method for anthelmintics in milk. | 2002 Nov 8 |
|
HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. | 2002 Oct 15 |
|
Quantitative chromatographic determination of several benzimidazole anthelmintic molecules in parasite material. | 2003 Dec 5 |
|
Population-S benzimidazole- and tetrahydropyrimidine-resistant small strongyles in a pony herd in Kentucky (1977-1999): effects of anthelmintic treatment on the parasites as determined in critical tests. | 2003 Nov |
|
Evaluation of a larval development assay (DrenchRite) for the detection of anthelmintic resistance in cyathostomin nematodes of horses. | 2004 May 7 |
|
Prevalence of anthelmintic resistant cyathostomes on horse farms. | 2004 Sep 15 |
|
Field studies on endoparasites of Thoroughbred foals on seven farms in central Kentucky in 2004. | 2006 Apr |
|
Parasite field study in central Kentucky on thoroughbred foals (born in 2004) treated with pyrantel tartrate daily and other parasiticides periodically. | 2007 Feb |
|
Evaluation of parasiticidal activity of fenbendazole, ivermectin, oxibendazole, and pyrantel pamoate in horse foals with emphasis on ascarids (Parascaris equorum) in field studies on five farms in Central Kentucky in 2007. | 2008 Jul |
|
Restrictions of anthelmintic usage: perspectives and potential consequences. | 2009 Sep 25 |
|
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. | 2013 Sep 5 |
Patents
Sample Use Guides
Oxibendazole should be administered orally. The dose depends on species, and constitutes 10-20 mg/kg for dogs, 10-50 mg/kg for cats, 5-15 mg/kg for cattle. 10-15 mg/kg for horses.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3755220
To study binding of oxibendazole to H. contortus tubulin, 10 [3H]oxibendazole (OBZ) was used as a radioligand. Solution was incubated for 15 min at 37°C. Binding was terminated by the addition of a charcoal solution. After 5 min incubation to adsorb unbound drug, the charcoal was sedimented by 5 min centrifugation, and bound [3H]OBZ was counted.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.1638
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
||
|
CFR |
21 CFR 520.623
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
||
|
WHO-VATC |
QP52AC57
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
||
|
WHO-VATC |
QP52AC07
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
20559-55-1
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
SUB09521MIG
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
C011321
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
4622
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
022N12KJ0X
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
3437
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
m8305
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | Merck Index | ||
|
022N12KJ0X
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
100000083040
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
OXIBENDAZOLE
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
CHEMBL1087630
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
C66262
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
DTXSID5045625
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
1009342
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB04910
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
243-877-7
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY | |||
|
758459
Created by
admin on Fri Dec 15 15:40:52 UTC 2023 , Edited by admin on Fri Dec 15 15:40:52 UTC 2023
|
PRIMARY |
ACTIVE MOIETY